Universal Influenza Vaccines 2022

5-7 September 2022, The Richard Doll Building, University of Oxford, Oxford, UK

  • Increase font size
  • Default font size
  • Decrease font size

Posters

Provisional Conference Programme | Poster Session

‘Evaluation of vaccine efficacy against Moroccan strain of LPAI H9N2 in experimental models in broiler chicken’
Yassmina Bidoudan
(Hassan II Veterinary and Agronomy Institute, Morocco)

‘Evaluation of exploratory cellular and humoral responses to FLU-v, a universal influenza peptide vaccine tested in a clinical phase IIb trial’
F. Oftung1, L.M. Næss1, D.B.-Bratlie1, I. Laake1, E. James2, G. Stoloff2 and O. Pleguezuelos2
(1 Infection Control and Environmental Health, Norwegian Institute of Public Health (NIPH), Norway; 2 PepTcell Ltd (trading as SEEK), London, UK)

 

UIV 2022 Delegates

Login details will be supplied after you have registered for the event.


UIV 2022 Sponsors

  • FluConsult
  • BiondVax
  • NanoFCM
  • DNAvaccine.com
  • VisMederi
  • Izon Science
  • ISIRV
  • Sanofi Pasteur
  • The Native Antigen Company
  • Vaxart
  • APACI

UIV 2022 Mailing List

Name
E-mail Address
What is 3+2-1?